🇺🇸 FDA
Patent

US 7267978

Chimeric transcriptional regulatory element compositions and methods for increasing prostate-targeted gene expression

granted A61KA61K48/00

Quick answer

US patent 7267978 (Chimeric transcriptional regulatory element compositions and methods for increasing prostate-targeted gene expression) held by The Regents of the University of California expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
53
CPC classes
A61K, A61K48/00